Press Releases

Rhenovia Pharma, a leading biotech company in biosimulation applied to the discovery of new medications to treat neurodegenerative, neurological and psychiatric diseases, announces today the filing of patents of a new method, a drug candidate, RHEDAR(TM) and a...

Ariana Pharma, a provider of “non-statistical” clinical data analysis technology to the pharmaceutical industry including the FDA, announces today that it has expanded its global operations by establishing a permanent US office in Cambridge, Massachusetts to service growing...

Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., continues due diligence toward an agreement to help develop a promising new treatment for Traumatic Brain Injury (TBI), concern continues to grow over the troubling incidence of TBI among...

Patients with diabetes mellitus experience significantly higher rates of surgical and systemic complications, higher mortality and increased length of stay during hospitalization following 11 major elective procedures, according to research presented today at the American Association of Clinical...

Pre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American Association of Clinical Endocrinologists (AACE)21st Annual Meeting...

Biotechnology Industry Organization President and CEO Jim Greenwood issued the following statement in support of the U.S. Senate’s approval of the Food and Drug Administration Safety and Innovation Act: “BIO commends the bipartisan Senate...

Mylan Inc.today announced that its UK and Italy-based subsidiaries have launched Ibandronic Acid Film Coated Tablets POM, 150 mg. This product is the generic version of Roche's Bonviva® Tablets, a treatment for osteoporosis. Mylan CEO Heather...